A Randomized, Assessor-blind Trial Comparing MENOPUR (Menotropins for Injection) and Recombinant FSH (Follicle Stimulating Hormone) in a GnRH Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population

Trial Profile

A Randomized, Assessor-blind Trial Comparing MENOPUR (Menotropins for Injection) and Recombinant FSH (Follicle Stimulating Hormone) in a GnRH Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Oct 2017

At a glance

  • Drugs Menotropin (Primary) ; Follitropin alfa
  • Indications Female infertility
  • Focus Therapeutic Use
  • Acronyms MEGASET HR
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 30 Oct 2017 According to a Ferring Pharmaceuticals media release, additional data from this study is anticipated for release in 2018.
    • 30 Oct 2017 Results presened in a Ferring Pharmaceuticals Media Release.
    • 30 Oct 2017 According to a Ferring Pharmaceuticals media release, primary endpoint has been met. (Ongoing pregnancy rate)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top